The ADAM17 inhibitor ZLDI-8 sensitized hepatocellular carcinoma cells to sorafenib through Notch1-integrin β-talk.
Saved in:
| Title: | The ADAM17 inhibitor ZLDI-8 sensitized hepatocellular carcinoma cells to sorafenib through Notch1-integrin β-talk. |
|---|---|
| Authors: | Xu, Chang1,2 (AUTHOR), Gao, Xudong2 (AUTHOR), Ren, Tianshu2 (AUTHOR), Geng, Hefeng1,2 (AUTHOR), Yang, Kaisi1,2 (AUTHOR), Huang, Yaoguang1 (AUTHOR), Zhang, Weige1 (AUTHOR), Hou, Shanbo3 (AUTHOR), Song, Aigang3 (AUTHOR), Zhang, Yingshi1,2 (AUTHOR) zhangyingshi526@163.com, Zhao, Qingchun1,2 (AUTHOR) zhaoqingchun1967@163.com |
| Source: | Pharmacological Research. May2024, Vol. 203, pN.PAG-N.PAG. 1p. |
| Database: | Academic Search Ultimate |
| ISSN: | 10436618 |
|---|---|
| DOI: | 10.1016/j.phrs.2024.107142 |
